Adagene

Adagene Goodwill

Goodwill of Adagene (ADAG) as of Oct 19, 2026.

Goodwill

-USD

Last updated:

Goodwill of Adagene is 2026 - USD. Goodwill of Adagene was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adagene Stock analysis

What does Adagene do? Adagene Inc., based in Suzhou, China, is a clinical-stage biotechnology company focused on developing monoclonal antibody drugs for cancer treatment. The company operates in the Health Care sector, with its lead candidates ADG126 and ADG116 in phase 1b/2 trials for various cancers, alongside other pipeline products in clinical and preclinical stages. Listed on 9 February 2021, Adagene employs 128 people and is dedicated to advancing innovative therapies for solid tumors and hematologic malignancies. Adagene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adagene stock

On Eulerpool you can find the complete historical development of Goodwill Adagene since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Adagene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Adagene

All Key Metrics — Adagene